世界のソマトスタチン受容体2型市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Somatostatin Receptor Type 2 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6017 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ソマトスタチン受容体2型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CRN-00808、酢酸ランレオチド、PRL-2903、その他）、用途別市場規模（ホルモン障害、腫瘍、代謝障害、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ソマトスタチン受容体2型の市場動向 ・企業の競争状況、市場シェア ・ソマトスタチン受容体2型の種類別市場規模と予測2016-2027（CRN-00808、酢酸ランレオチド、PRL-2903、その他） ・ソマトスタチン受容体2型の用途別市場規模と予測2016-2027（ホルモン障害、腫瘍、代謝障害、その他） ・ソマトスタチン受容体2型の北米市場規模2016-2027（アメリカ、カナダ） ・ソマトスタチン受容体2型の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ソマトスタチン受容体2型のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ソマトスタチン受容体2型の中南米市場規模2016-2027（メキシコ、ブラジル） ・ソマトスタチン受容体2型の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amryt Pharma plc、Crinetics Pharmaceuticals Inc、Daewoong Pharmaceutical Co Ltd、Ipsen SA、Progenics Pharmaceuticals Inc、Strongbridge Biopharma plc、Zucara Therapeutics Inc） ・結論

Market Analysis and Insights: Global Somatostatin Receptor Type 2 Market
The global Somatostatin Receptor Type 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Somatostatin Receptor Type 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Somatostatin Receptor Type 2 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Somatostatin Receptor Type 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Somatostatin Receptor Type 2 market.

Global Somatostatin Receptor Type 2 Scope and Market Size
Somatostatin Receptor Type 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Somatostatin Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CRN-00808
Lanreotide Acetate
PRL-2903
Others

Segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amryt Pharma plc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Ipsen SA
Progenics Pharmaceuticals Inc
Strongbridge Biopharma plc
Zucara Therapeutics Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CRN-00808
1.2.3 Lanreotide Acetate
1.2.4 PRL-2903
1.2.5 Others
1.3 Market by Application
1.3.1 Global Somatostatin Receptor Type 2 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Somatostatin Receptor Type 2 Market Perspective (2016-2027)
2.2 Somatostatin Receptor Type 2 Growth Trends by Regions
2.2.1 Somatostatin Receptor Type 2 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Somatostatin Receptor Type 2 Historic Market Share by Regions (2016-2021)
2.2.3 Somatostatin Receptor Type 2 Forecasted Market Size by Regions (2022-2027)
2.3 Somatostatin Receptor Type 2 Industry Dynamic
2.3.1 Somatostatin Receptor Type 2 Market Trends
2.3.2 Somatostatin Receptor Type 2 Market Drivers
2.3.3 Somatostatin Receptor Type 2 Market Challenges
2.3.4 Somatostatin Receptor Type 2 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Somatostatin Receptor Type 2 Players by Revenue
3.1.1 Global Top Somatostatin Receptor Type 2 Players by Revenue (2016-2021)
3.1.2 Global Somatostatin Receptor Type 2 Revenue Market Share by Players (2016-2021)
3.2 Global Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Somatostatin Receptor Type 2 Revenue
3.4 Global Somatostatin Receptor Type 2 Market Concentration Ratio
3.4.1 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Somatostatin Receptor Type 2 Revenue in 2020
3.5 Somatostatin Receptor Type 2 Key Players Head office and Area Served
3.6 Key Players Somatostatin Receptor Type 2 Product Solution and Service
3.7 Date of Enter into Somatostatin Receptor Type 2 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Somatostatin Receptor Type 2 Breakdown Data by Type
4.1 Global Somatostatin Receptor Type 2 Historic Market Size by Type (2016-2021)
4.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2022-2027)

5 Somatostatin Receptor Type 2 Breakdown Data by Application
5.1 Global Somatostatin Receptor Type 2 Historic Market Size by Application (2016-2021)
5.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Somatostatin Receptor Type 2 Market Size (2016-2027)
6.2 North America Somatostatin Receptor Type 2 Market Size by Type
6.2.1 North America Somatostatin Receptor Type 2 Market Size by Type (2016-2021)
6.2.2 North America Somatostatin Receptor Type 2 Market Size by Type (2022-2027)
6.2.3 North America Somatostatin Receptor Type 2 Market Size by Type (2016-2027)
6.3 North America Somatostatin Receptor Type 2 Market Size by Application
6.3.1 North America Somatostatin Receptor Type 2 Market Size by Application (2016-2021)
6.3.2 North America Somatostatin Receptor Type 2 Market Size by Application (2022-2027)
6.3.3 North America Somatostatin Receptor Type 2 Market Size by Application (2016-2027)
6.4 North America Somatostatin Receptor Type 2 Market Size by Country
6.4.1 North America Somatostatin Receptor Type 2 Market Size by Country (2016-2021)
6.4.2 North America Somatostatin Receptor Type 2 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Somatostatin Receptor Type 2 Market Size (2016-2027)
7.2 Europe Somatostatin Receptor Type 2 Market Size by Type
7.2.1 Europe Somatostatin Receptor Type 2 Market Size by Type (2016-2021)
7.2.2 Europe Somatostatin Receptor Type 2 Market Size by Type (2022-2027)
7.2.3 Europe Somatostatin Receptor Type 2 Market Size by Type (2016-2027)
7.3 Europe Somatostatin Receptor Type 2 Market Size by Application
7.3.1 Europe Somatostatin Receptor Type 2 Market Size by Application (2016-2021)
7.3.2 Europe Somatostatin Receptor Type 2 Market Size by Application (2022-2027)
7.3.3 Europe Somatostatin Receptor Type 2 Market Size by Application (2016-2027)
7.4 Europe Somatostatin Receptor Type 2 Market Size by Country
7.4.1 Europe Somatostatin Receptor Type 2 Market Size by Country (2016-2021)
7.4.2 Europe Somatostatin Receptor Type 2 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size (2016-2027)
8.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type
8.2.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type (2016-2027)
8.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application
8.3.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application (2016-2027)
8.4 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region
8.4.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Somatostatin Receptor Type 2 Market Size (2016-2027)
9.2 Latin America Somatostatin Receptor Type 2 Market Size by Type
9.2.1 Latin America Somatostatin Receptor Type 2 Market Size by Type (2016-2021)
9.2.2 Latin America Somatostatin Receptor Type 2 Market Size by Type (2022-2027)
9.2.3 Latin America Somatostatin Receptor Type 2 Market Size by Type (2016-2027)
9.3 Latin America Somatostatin Receptor Type 2 Market Size by Application
9.3.1 Latin America Somatostatin Receptor Type 2 Market Size by Application (2016-2021)
9.3.2 Latin America Somatostatin Receptor Type 2 Market Size by Application (2022-2027)
9.3.3 Latin America Somatostatin Receptor Type 2 Market Size by Application (2016-2027)
9.4 Latin America Somatostatin Receptor Type 2 Market Size by Country
9.4.1 Latin America Somatostatin Receptor Type 2 Market Size by Country (2016-2021)
9.4.2 Latin America Somatostatin Receptor Type 2 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size (2016-2027)
10.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type
10.2.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2016-2027)
10.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application
10.3.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2016-2027)
10.4 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country
10.4.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amryt Pharma plc
11.1.1 Amryt Pharma plc Company Details
11.1.2 Amryt Pharma plc Business Overview
11.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Introduction
11.1.4 Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.1.5 Amryt Pharma plc Recent Development
11.2 Crinetics Pharmaceuticals Inc
11.2.1 Crinetics Pharmaceuticals Inc Company Details
11.2.2 Crinetics Pharmaceuticals Inc Business Overview
11.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
11.2.4 Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.2.5 Crinetics Pharmaceuticals Inc Recent Development
11.3 Daewoong Pharmaceutical Co Ltd
11.3.1 Daewoong Pharmaceutical Co Ltd Company Details
11.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
11.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Introduction
11.3.4 Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.3.5 Daewoong Pharmaceutical Co Ltd Recent Development
11.4 Ipsen SA
11.4.1 Ipsen SA Company Details
11.4.2 Ipsen SA Business Overview
11.4.3 Ipsen SA Somatostatin Receptor Type 2 Introduction
11.4.4 Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.4.5 Ipsen SA Recent Development
11.5 Progenics Pharmaceuticals Inc
11.5.1 Progenics Pharmaceuticals Inc Company Details
11.5.2 Progenics Pharmaceuticals Inc Business Overview
11.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
11.5.4 Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.5.5 Progenics Pharmaceuticals Inc Recent Development
11.6 Strongbridge Biopharma plc
11.6.1 Strongbridge Biopharma plc Company Details
11.6.2 Strongbridge Biopharma plc Business Overview
11.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Introduction
11.6.4 Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.6.5 Strongbridge Biopharma plc Recent Development
11.7 Zucara Therapeutics Inc
11.7.1 Zucara Therapeutics Inc Company Details
11.7.2 Zucara Therapeutics Inc Business Overview
11.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Introduction
11.7.4 Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021)
11.7.5 Zucara Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CRN-00808
Table 3. Key Players of Lanreotide Acetate
Table 4. Key Players of PRL-2903
Table 5. Key Players of Others
Table 6. Global Somatostatin Receptor Type 2 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Somatostatin Receptor Type 2 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Somatostatin Receptor Type 2 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Somatostatin Receptor Type 2 Market Share by Regions (2016-2021)
Table 10. Global Somatostatin Receptor Type 2 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Somatostatin Receptor Type 2 Market Share by Regions (2022-2027)
Table 12. Somatostatin Receptor Type 2 Market Trends
Table 13. Somatostatin Receptor Type 2 Market Drivers
Table 14. Somatostatin Receptor Type 2 Market Challenges
Table 15. Somatostatin Receptor Type 2 Market Restraints
Table 16. Global Somatostatin Receptor Type 2 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Somatostatin Receptor Type 2 Market Share by Players (2016-2021)
Table 18. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Receptor Type 2 as of 2020)
Table 19. Ranking of Global Top Somatostatin Receptor Type 2 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Somatostatin Receptor Type 2 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Somatostatin Receptor Type 2 Product Solution and Service
Table 23. Date of Enter into Somatostatin Receptor Type 2 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2016-2021)
Table 27. Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Somatostatin Receptor Type 2 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2016-2021)
Table 31. Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Somatostatin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Somatostatin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Somatostatin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Somatostatin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Somatostatin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Somatostatin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Somatostatin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Somatostatin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Somatostatin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Somatostatin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Somatostatin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Somatostatin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Somatostatin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Somatostatin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Somatostatin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amryt Pharma plc Company Details
Table 64. Amryt Pharma plc Business Overview
Table 65. Amryt Pharma plc Somatostatin Receptor Type 2 Product
Table 66. Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 67. Amryt Pharma plc Recent Development
Table 68. Crinetics Pharmaceuticals Inc Company Details
Table 69. Crinetics Pharmaceuticals Inc Business Overview
Table 70. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
Table 71. Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 72. Crinetics Pharmaceuticals Inc Recent Development
Table 73. Daewoong Pharmaceutical Co Ltd Company Details
Table 74. Daewoong Pharmaceutical Co Ltd Business Overview
Table 75. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product
Table 76. Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 77. Daewoong Pharmaceutical Co Ltd Recent Development
Table 78. Ipsen SA Company Details
Table 79. Ipsen SA Business Overview
Table 80. Ipsen SA Somatostatin Receptor Type 2 Product
Table 81. Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 82. Ipsen SA Recent Development
Table 83. Progenics Pharmaceuticals Inc Company Details
Table 84. Progenics Pharmaceuticals Inc Business Overview
Table 85. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
Table 86. Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 87. Progenics Pharmaceuticals Inc Recent Development
Table 88. Strongbridge Biopharma plc Company Details
Table 89. Strongbridge Biopharma plc Business Overview
Table 90. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product
Table 91. Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 92. Strongbridge Biopharma plc Recent Development
Table 93. Zucara Therapeutics Inc Company Details
Table 94. Zucara Therapeutics Inc Business Overview
Table 95. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product
Table 96. Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 97. Zucara Therapeutics Inc Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Somatostatin Receptor Type 2 Market Share by Type: 2020 VS 2027
Figure 2. CRN-00808 Features
Figure 3. Lanreotide Acetate Features
Figure 4. PRL-2903 Features
Figure 5. Others Features
Figure 6. Global Somatostatin Receptor Type 2 Market Share by Application: 2020 VS 2027
Figure 7. Hormonal Disorder Case Studies
Figure 8. Oncology Case Studies
Figure 9. Metabolic Disorder Case Studies
Figure 10. Others Case Studies
Figure 11. Somatostatin Receptor Type 2 Report Years Considered
Figure 12. Global Somatostatin Receptor Type 2 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Somatostatin Receptor Type 2 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Somatostatin Receptor Type 2 Market Share by Regions: 2020 VS 2027
Figure 15. Global Somatostatin Receptor Type 2 Market Share by Regions (2022-2027)
Figure 16. Global Somatostatin Receptor Type 2 Market Share by Players in 2020
Figure 17. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Receptor Type 2 as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Somatostatin Receptor Type 2 Revenue in 2020
Figure 19. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2016-2021)
Figure 20. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2022-2027)
Figure 21. North America Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Somatostatin Receptor Type 2 Market Share by Type (2016-2027)
Figure 23. North America Somatostatin Receptor Type 2 Market Share by Application (2016-2027)
Figure 24. North America Somatostatin Receptor Type 2 Market Share by Country (2016-2027)
Figure 25. United States Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Somatostatin Receptor Type 2 Market Share by Type (2016-2027)
Figure 29. Europe Somatostatin Receptor Type 2 Market Share by Application (2016-2027)
Figure 30. Europe Somatostatin Receptor Type 2 Market Share by Country (2016-2027)
Figure 31. Germany Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Region (2016-2027)
Figure 41. China Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Somatostatin Receptor Type 2 Market Share by Type (2016-2027)
Figure 49. Latin America Somatostatin Receptor Type 2 Market Share by Application (2016-2027)
Figure 50. Latin America Somatostatin Receptor Type 2 Market Share by Country (2016-2027)
Figure 51. Mexico Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2016-2027)
Figure 57. Turkey Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Somatostatin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amryt Pharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 61. Crinetics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 62. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 63. Ipsen SA Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 64. Progenics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 65. Strongbridge Biopharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 66. Zucara Therapeutics Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---